Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Stoss

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Histopathology|April 22, 2008
Assessment of a HER2 scoring system for gastric cancer: results from a validation studyM Hofmann, O Stoss, D Shi, et al.
Der Pathologe|May 6, 2010
[Her2 testing in gastric cancer. What is different in comparison to breast cancer?]J Rüschoff, I Nagelmeier, G Baretton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2013
HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumabL Zabaglo, O Stoss, J Rüschoff, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 12, 2014
Human epidermal growth factor receptor 2 overexpression and amplification in endoscopic biopsies and resection specimens in esophageal and junctional adenocarcinomaP van Hagen, K Biermann, J E Boers, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Histopathology|April 22, 2008
Assessment of a HER2 scoring system for gastric cancer: results from a validation studyM Hofmann, O Stoss, D Shi, et al.
Der Pathologe|May 6, 2010
[Her2 testing in gastric cancer. What is different in comparison to breast cancer?]J Rüschoff, I Nagelmeier, G Baretton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2013
HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumabL Zabaglo, O Stoss, J Rüschoff, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 12, 2014
Human epidermal growth factor receptor 2 overexpression and amplification in endoscopic biopsies and resection specimens in esophageal and junctional adenocarcinomaP van Hagen, K Biermann, J E Boers, et al.
Pageof 2